Pulse Brain · Growing Health Evidence Index
Peer-reviewed

Sarcopenia and Cardiovascular Diseases

Abdulla A. Damluji, Maha Alfaraidhy, Noora Alhajri, Namit Rohant, Manish Kumar, Christina Al Malouf, Samira Bahrainy, Min Ji Kwak, Wayne Batchelor, Daniel E. Forman, Michael W. Rich, James N. Kirkpatrick, Ashok Krishnaswami, Karen P. Alexander, Gary Gerstenblith, Peggy M. Cawthon, Christopher R. deFilippi, Parag Goyal

Circulation · 2023

Read source ↗ All evidence

Summary

Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by chronic comorbidities including cardiovascular diseases, chronic kidney disease, and cancer. Sarcopenia is associated with faster progression of cardiovascular diseases and higher risk of mortality, falls, and reduced quality of life, particularly among older adults. Although the pathophysiologic mechanisms are complex, the broad underlying cause of sarcopenia includes an imbalance between anabolic and catabolic muscle homeostasis with or without neuronal degeneration. The intrinsic molecular mechanisms of aging, chronic illness, malnutrition, and immobility are associated with the development of sarcopenia. Screening and testing for sarcopenia may be particularly important among those with chronic

Source type
Peer-reviewed study
DOI
10.1161/circulationaha.123.064071
Catalogue ID
SNmojbinfq-qmmllg
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.